Era Biology will host global live webinar at 12th July. Due to the fact that WHO has declared that antimicrobial resistance (AMR) is one of the top 10 global public health threats facing humanity. ...
“Innovative technology leads the future”, Era Biology closely follows the theme of this exhibition and leads the development of microbial diagnosis to intelligence.
The world’s first au...
On May 19th, Era Biology host the global live webinar. The webinar talks about three different solutions using fungus (1-3)-β-D Glucan Test to achieve early and rapid diagnosis of invasive fungal d...
Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
Era Biology has launched a new product series which is Chemiluminescence Immunoassay (CLIA) detection kit for detecting inflammation and bacterial infections. The kit is run on Full-Automatic Chemi...
Tianjin, China – September 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field sinc...